Back to results
US 2026/0297121 A1Published application
Mithramycin (mtm) 2’ oximes
AssigneeUniversity of Kentucky Research Foundation
InventorsJon S. Thorson, Markos Leggas, Yang Liu, Aarajana Shrestha
Life of this patent
Estimating the term…
Abstract
Compounds described herein are mithramycin (MTM) oxide (OX) derivatives. These compounds are useful for treatment of cancers and neuro-diseases.
Claims5
A compound having the following formula:
- or a pharmaceutically acceptable salt thereof,
- wherein R is
Dependencies are inferred from the claim text.